Nuevocor Closes Us$24M Series A Financing To Advance Novel Gene Therapies For Cardiomyopathies
Amount Raised
$24 Million
Round Type
Series A
Description
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million Series A financing round. The round was co-led by EVX Ventures and Boehringer Ingelheim Venture Fund (BIVF), with EDBI, Xora Innovation, SEEDS Capital and other investors joining the syndicate.
Quick answer
Nuevocor raised $24 Million in a Series A round, dated June 18, 2021. Nuevocor is based in Singapore, Southeast Asia, Singapore.
- How much did Nuevocor raise?
- Nuevocor raised $24 Million in a Series A round on June 18, 2021.
- What does Nuevocor do?
- Nuevocor, with offices in USA and Singapore, is developing genetic medicines for untreatable genetic cardiomyopathies by leveraging insights from our PrOSIA mechanobiology platform.
- Where is Nuevocor based and how big is it?
- Nuevocor is based in Singapore, Southeast Asia, Singapore. Fundz records about 31 employees.
- Who are the decision-makers at Nuevocor?
- Fundz holds 1 contact at Nuevocor, including the Co-founder and Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Nuevocor that raised within 45 days of this round, from Fundz verified event records.
- ProtoKinetix raised $24K on August 2, 2021.
- Cerillo, Inc. raised $460K (Seed) on August 2, 2021.
- Stimcell Energetics Inc. raised $5K (Pre-Seed) on August 2, 2021.
- Vascular Perfusion Solutions raised $1.1M on August 2, 2021.
- Neuralink raised $205M (Funding Round) on July 30, 2021.
- Cerium Pharmaceuticals, Inc. raised $8.9M on July 30, 2021.
Who to call at Nuevocor, and when
A new round usually means Nuevocor is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nuevocor raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nuevocor, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nuevocor. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nuevocor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNuevocor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.